As well as in the regulation of cell proliferation. Is used with the Food taken too little selenium, affected enzymes can not work properly and may cause dysregulation of the cell cycle. In experimental studies, researchers have to prove that selenium interferes in the regulation of cell cycle and promotes natural, programmed cell death. This, according to the researchers, the formation could be prevented in the experimental approaches in the laboratory of cancer cells. The experimental studies are supported by a new study from the German Cancer Research Center. The researchers from Heidelberg investigated the content of selenium in the blood of men with prostate cancer and those without. They noted that with increase of selenium in the blood, decreases the risk of prostate cancer.
Similar found a group of researchers from Berlin out, which also investigated the Selenium levels in the blood in patients with and without prostate cancer. Already almost as expected, they found less selenium than in the comparison group patients with prostate cancer. Tissue samples from the prostate cancer-ridden, show that in the diseased prostate In addition to selenium zinc and vitamins A, C, and are humiliated. What now for the practical application of these results? According to the researchers, they offer an approach to the prevention of prostate cancer. The missing microelements and vitamins are permanently replaced, so the risk for prostate cancer should be lower.
French researchers in a very large long-term study have done exactly that. You have more than seven years daily swallow a cocktail of special vitamins and trace elements or a Certificate Supplement about 5,000 healthy men. The cocktail of vitamins and trace elements was tailored to the specific situation in men and contained the trace elements selenium and zinc in addition to the vitamins A, C, E. At the end of the study after 7 years the researchers found that the men who had received the cocktail with the selected micro-nutrients, only about half as often were sick in the meantime on prostate cancer, like the men in the comparison group with the preparation of the Bill.